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Background
The specific inhibitor of the cGMP degrading enzyme
phosphodiesterase 5 (PDE5), sildenafil (Viagra®), induces
migraine without significant cerebral artery dilatation in
vivo. This is in contrast to other migraine inducing sub-
stances such as glyceryl trinitrate and histamine which are
effective vasodilators. Sildenafil is also recently found to
enhance functional recovery, neurogenesis and angiogen-
esis in stroke models. We evaluated the presence of PDE5
and functional effects of three selective PDE inhibitors in
human and guinea pig cerebral arteries.
Materials and methods
RT-PCR and Western blot were used to establish the pres-
ence of PDE5 mRNA and protein respectively. The effects
of sildenafil, UK-114,542 (both PDE5 specific) and UK-
90,234 (PDE1 specific) on cyclic nucleotide hydrolysis
were investigated using homogenates of human and
guinea pig cerebral arteries. In isolated guinea pig basilar
arteries the cerebral vasodilator responses of the PDE
inhibitors were investigated. Concomitantly the tissue lev-
els of cAMP and cGMP were analysed.
Results
PDE5A mRNA and protein were present in human middle
cerebral artery. Sildenafil and UK-114,542 caused a con-
centration-dependent inhibition of cGMP hydrolysis.
Sildenafil induced an endothelium dependent vasodilata-
tion (pEC50 6.0 ± 0.3), which was less than 10 % of maxi-
mal dilatation within the clinically effective plasma
concentrations after oral sildenafil 100 mg (40 nM) (See
figure 1). The dilatation was augmented by sodium nitro-
prusside (SNP) pre-treatment. UK-114,542 (pEC50 8.6 ±
0.1) was a more potent vasodilator than sildenafil. The
PDE1 inhibitor UK-90,234 elicited a non-specific
response with poor potency (pEC50 5.2 ± 0.1). The
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Concentration-response curve for UK-90,234 (square), UK-
114,542 (circle) and sildenafil (triangle) without (filled sym-
bols) and with (open symbols) pre-treatment with the inhibi-
tor of soluble guanylate cyclase, ODQ (10 µM), in intact 
arteries. Relaxation is given as % relaxation of pre-contrac-
tion and each point shows mean ± S.E.M. In high concentra-
tions all compounds elicited a small cGMP-independent 
dilatory response.Page 1 of 2
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vasodilatation was attenuated by endothelial removal or
pharmacological inhibition of endogenous cGMP pro-
duction, but a cGMP-independent dilatory response was
seen at high concentrations.
Conclusion
Sildenafil in vitro mainly dilates cerebral arteries above
relevant plasma concentrations of sildenafil, unless a
nitric oxide donor is co-administered. These results sup-
ports the lack of vascular response previously found in
human in vivo studies and may suggest a possible neuro-
nal rather than vascular effect of sildenafil in migraine
induction.Page 2 of 2
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